Skip to main content

Argentina Commits to Easing Entry Barriers for Indian Pharma Sector

Written by: Team Angel OneUpdated on: 29 Aug 2026, 11:07 pm IST
Argentina pledges to lower entry barriers for Indian pharma, aiming to enhance healthcare access and boost bilateral trade.
Argentina Commits to Easing Entry Barriers
Share

Argentina has pledged to reduce regulatory barriers to facilitate the entry of Indian pharmaceutical companies into its market.  

This decision was communicated during the visit of India's Commerce Secretary, Rajesh Agarwal, to Buenos Aires, underlining efforts to expand bilateral cooperation in the pharmaceutical sector, as per the news report. 

Pharmaceutical Regulatory Framework Enhancement 

The Argentine government aims to upgrade India's status from Annex II to Annex I in its pharmaceutical regulatory framework, making it easier for Indian companies to market their products. This move is designed to foster the availability of quality and affordable healthcare in Argentina. 

Expansion of Bilateral Trade and Investment 

Bilateral trade between India and Argentina reached $6.5 billion in 2025, reflecting over 17% annual growth. The countries are exploring investment opportunities across mining, energy, and infrastructure sectors, including lithium mining activities by India’s KABIL in Catamarca, Argentina. 

Broader Cooperation and Agreement 

The discussions also identified additional areas for cooperation in aviation, space technology, telecommunications, and digital services such as 5G and artificial intelligence. Furthermore, India and Argentina signed a social security agreement to support professionals working in each other's countries. 

Read More: Waaree Energies Share Price in Focus; Secures 700 MW Solar Project in Maharashtra! 

India-Mercosur Trade Block Collaboration 

Efforts to expand the existing preferential trade agreement between India and the Mercosur trade bloc, comprising Brazil, Argentina, Uruguay, and Paraguay, are ongoing. The adoption of digital certificates of origin aims to streamline cross-border commerce. 

Conclusion 

Argentina's commitment to reducing entry barriers for Indian pharmaceuticals aligns with increasing bilateral trade, which surpassed $6.5 billion in 2025 and maintained a 17% annual growth. Enhanced cooperation spans multiple sectors, including digital infrastructure and mining. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Published on: Aug 29, 2026, 5:37 PM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More
Enjoy Zero Brokerage on Equity Delivery
10 Cr+DOWNLOADS

Enjoy ₹0 Account Opening Charges

Get the link to download the App

Scan this QR code to download the app
Get it on Google PlayDownload on the App Store

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91